This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Emerging Technologies and Novel Approaches in Antibody Engineering and Therapeutics

Emerging technologies such as AI, next generation sequencing and display systems are changing the way antibodies are being engineered at a rapid rate. At the same time, novel approaches to identifying targets and delivering antibodies are improving therapeutic effectiveness. However, there are still plenty of challenges that need to be overcome.

The Antibody Engineering & Therapeutics conference series recently (Aug 2019) conducted a survey of industry professionals from pharma, biotechs, academia, CDMOs, CROs, service providers and consultancies around the world. This report based on 211 responses reveals unique insights into the hottest potential opportunities and the biggest challenges around emerging technologies and novel approaches in antibody engineering and therapeutics.

Log in or Create an Informa Connect Account to Access this content

Creating an account also means you'll get special access to event updates and exclusive industry content.